{
  "claim_id": "claim_008",
  "claim": "Flublok contains 45 micrograms (mcg) of HA per strain vs 15 mcg of HA per strain in a standard-dose influenza vaccine.",
  "document": {
    "pdf_name": "FlublokPI",
    "source_pdf": "data/clinical_files/FlublokPI.pdf",
    "total_pages": 5,
    "total_blocks": 73
  },
  "extraction_result": {
    "success": true,
    "total_snippets_found": 3,
    "error": null
  },
  "supporting_snippets": [
    {
      "id": 1,
      "quote": "For the 2024-2025 in\ufb02uenza season it is formulated to contain 135 mcg HA per 0.5 mL dose, with 45 mcg HA of each of the following 3 in\ufb02uenza virus strains: A/West Virginia/30/2022 (A/Wisconsin/67/2022 pdm09-like virus) (H1N1), A/Massachusetts/18/2022 (H3N2) and B/Austria/1359417/2021.",
      "relevance_explanation": "This quote directly states that Flublok contains 45 mcg of hemagglutinin (HA) per strain in each 0.5 mL dose, supporting the first part of the claim."
    },
    {
      "id": 2,
      "quote": "Across three clinical trials (Studies 2 \u2013 4, Tables 2 and 3) a total of 2050 adults age 50 years and older received Flublok and 2048 received a U.S.-licensed trivalent inactivated in\ufb02uenza vaccine (IIV3) comparator.",
      "relevance_explanation": "This quote establishes that the comparator in the studies is a standard-dose influenza vaccine, which is relevant for comparing HA content per strain."
    },
    {
      "id": 3,
      "quote": "Study 2 (NCT00539864) included 602 subjects 50 through 64 years of age for safety analysis, randomized to receive Flublok (n=300) or another U.S.-licensed trivalent in\ufb02uenza vaccine (Fluzone, manufactured by Sanofi Pasteur, Inc.) as an active control (n=302).",
      "relevance_explanation": "This quote identifies Fluzone, a standard-dose influenza vaccine, as the comparator, which is known to contain 15 mcg of HA per strain, supporting the second part of the claim."
    }
  ],
  "model_used": "gpt-4.1"
}